Filing Details

Accession Number:
0001104659-21-032850
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-05 17:45:39
Reporting Period:
2021-03-04
Accepted Time:
2021-03-05 17:45:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1279704 Cellectar Biosciences Inc. CLRB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202770 V James Caruso C/O Cellectar Biosciences, Inc.,
100 Campus Drive
Florham Park NJ 07932
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-04 5,100 $1.70 86,401 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Acquisiton 2021-03-04 1,600,000 $0.00 1,600,000 $1.74
Common Stock Series A Warrants Acquisiton 2021-03-04 46,948 $0.19 4,694 $30.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,600,000 2031-03-04 No 4 A Direct
0 2016-04-20 2021-04-20 No 4 S Direct
Footnotes
  1. Mr. Caruso used the proceeds of the sale of the Series A Warrants, which expire in April 2021, to purchase shares of Cellectar's common stock.
  2. Ten warrants are convertible into one share of Cellectar's common stock at an exercise price of $30.40 per share of common stock.
  3. This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of shares available under Cellectar's equity incentive plans at Cellectar's 2021 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date.